FEDERATED HERMES, INC.

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 1056288 PITTSBURGH, PA

Position in XERS

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$4,969,515

-$1,741,355 QoQ

Shares Held

856,813

+0.2% QoQ

Ownership

0.496%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

FEDERATED HERMES, INC. holds $230,572,033 across 30 Drug Manufacturers - Specialty & Generic names. XERS ranks #10 (2.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc	2,423,350	$57,990,764
2	ZTS	Zoetis Inc.	452,980	$53,546,764
3	INDV	Indivior Pharmaceuticals, Inc.	1,217,721	$37,116,135
4	LQDA	Liquidia Corp	438,767	$16,559,066
5	AQST	Aquestive Therapeutics, Inc.	2,940,339	$12,202,406
6	IRWD	Ironwood Pharmaceuticals Inc	3,348,806	$11,754,308
7	TAK	Takeda Pharmaceutical Co Ltd	382,251	$7,079,288
8	PAHC	Phibro Animal Health Corp	100,677	$5,568,443

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,969,515	856,813	+0.2%	Shares	Defined	2026-05-11
2025-12-31	$6,710,870	854,888	+21.4%	Shares	Defined	2026-02-12
2025-09-30	$5,733,677	704,383	+1.9%	Shares	Defined	2025-11-03
2025-06-30	$3,228,749	691,381	+0.5%	Shares	Defined	2025-08-13
2025-03-31	$3,775,927	687,783	+36542.7%	Shares	Defined	2025-05-08
2024-12-31	$6,363	1,877	+937.0%	Shares	Defined	2025-02-13
2024-09-30	$515	181	-99.6%	Shares	Defined	2024-11-13
2023-06-30	$117,478	44,839	—	Shares	Defined	2023-08-14
No filing history on record for this holder in this stock.